Denver Investment Advisors’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-14,256
Closed -$121K 620
2013
Q3
$121K Buy
14,256
+3,144
+28% +$19.9K ﹤0.01% 547
2013
Q2
$46K Buy
+11,112
New +$59.7K ﹤0.01% 548

Denver Investment Advisors's ASTX Position: Q4 2013 in Review

Denver Investment Advisors sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 14,256 shares — an estimated $121K sold.

Denver Investment Advisors first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $121K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Denver Investment Advisors reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Denver Investment Advisors sold 14,256 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $121K.
  • Denver Investment Advisors first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Denver Investment Advisors's ASTEX PHARMACEUTICALS, INC COM position peaked at $121K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Denver Investment Advisors's 13F filing for Q4 2013, filed 13 Feb 2014.